DNA aneuploidy is an imbalance of chromosomal DNA content that has been highlighted as a predictor of biological behavior and risk of malignant transformation. To date, DNA aneuploidy in oral potentially malignant diseases (OPMD) has been shown to correlate strongly with severe dysplasia and high-risk lesions that appeared non-dysplastic can be identified by ploidy analysis. Nevertheless, the prognostic value of DNA aneuploidy in predicting malignant transformation of OPMD remains to be validated. The aim of this meta-analysis was to assess the role of DNA aneuploidy in predicting malignant transformation in OPMD. The questions addressed were (i) Is DNA aneuploidy a useful marker to predict malignant transformation in OPMD? (ii) Is DNA diploidy a useful negative marker of malignant transformation in OPMD? These questions were addressed using the PECO method.
content, as evaluated using image cytometry (DNA-ICM) and highresolution flow cytometry (DNA-FCM), permits the detection of abnormal nuclear DNA content. Both DNA-ICM and DNA-FCM techniques have been considered appropriate for routine analysis in many clinical applications including OPMDs. 6, 8 So far, DNA aneuploidy in OPMDs has been shown to correlate strongly with severe dysplasia 8, 16 and high-risk lesions that appeared non-dysplastic can be identified by ploidy analysis. 6, 17 Nevertheless, the prognostic value of DNA aneuploidy in predicting malignant transformation of OPMDs remains to be validated.
The aim of this systematic review and meta-analysis was to assess the role of DNA aneuploidy in predicting malignant transformation in OPMDs.
2 | ME TH ODS
| Data sources and search strategy
This systematic review was conducted following Preferred Reporting
Items for Systematic Review and Meta-Analyses (PRISMA) statement. 18 The literature search was conducted using PubMed, EMBASE and Scopus databases.
Searching in those databases was using a combination of text word and/or Medical Subject Heading (MeSH) terms. The search terms included ("aneuploidy" OR "DNA content") AND ("malignant transformation" OR "oral cancer risk") AND ("oral potentially malignant disorders" OR "oral precancer"). A manual search for the reference list of eligible studies was also carried out for further relevant articles. The gray literature was not searched.
The questions addressed were as follows:
• Is DNA aneuploidy a useful marker to predict malignant transformation in OPMDs?
• Is DNA diploidy a useful negative marker of malignant transformation in OPMDs?
These questions were addressed using the PECO method. 
| Study selection
Eligible studies were selected if they met the following criteria: (i)
original cohort studies conducted either retrospectively or prospectively; (ii) oral potentially malignant disorders were assessed; (iii) DNA ploidy analysis should be investigated as exposure of interest;
(iv) the primary outcome should be clearly reported as malignant transformation, irrespective of dysplasia grade; and (v) they were accessible and published as full papers. Copenhagen, Denmark) was used in this meta-analysis and a P value ˂.05 was considered statistically significant. If there was significant heterogeneity among studies, the random-effects model was used;
| Statistical analysis
otherwise, the fixed-effects model was applied. Between-study heterogeneity was examined using the Q-statistic and the I 2 statistic.
Funnel plots and qualitative analysis of specific variables of the ploidy analysis method were used to assess publication bias. Furthermore, a sensitivity analysis was performed to examine the robustness of the pooled results, using the leave-one-out approach.
3 | RESULTS
| Selection and characteristics of the studies
A total of 611 articles (579 from database, 32 from manual search)
were recorded, of which 84 were excluded as duplicate records.
After reviewing the titles and abstracts, 402 records were excluded.
Secondary screening yielded 23 articles to be evaluated for eligibility.
Fourteen studies were further excluded based on the inclusion and exclusion criteria and three final studies were excluded as they either exclusively investigated cases of proliferative verrucous leukoplakia 19, 20 or exclusively lichen planus. 17 Finally, DNA ploidy analysis for malignant progression of OPMD was assessed in five studies, totalizing 528 cases ( Figure 1 and Table 1) . 16, [21] [22] [23] [24] Of five studies, two included all types of OPMD, two included dysplastic lesions and one included leukoplakia (Table 1) . In all eligible studies, DNA ploidy analysis was carried out on formalin-fixed paraffin-embedded (FFPE) tissues using image-based cytometry.
The studies by Sperandio et al. (2013) , 16 
| Quantitative synthesis
Meta-analysis was performed on the five shortlisted studies for systematic review.
| DNA aneuploidy and malignant progression of OPMD
Five studies assessing aneuploidy as a risk marker of malignant change were pooled into the meta-analysis. As shown in Figure 2 , aneuploidy is associated with a 3.12-fold increased risk to progress into cancer (RR=3.12, 95% CI 1. 
| DNA diploidy and no malignant progression
Based on the five studies meta-analyzed, "no malignant progression" was more likely to occur in DNA diploid OPMD by 82% when compared to aneuploidy (RR=0.18, 95% CI 0.08-0.41), as illustrated in Figure 3 . High heterogeneity was observed in this analysis (I 2 =91%;
P<.00001), although, again, removing the study by Bremmer et al.
2011 22 , heterogeneity dropped to moderate (I 2 =49%; P<.12)
( Table 3 ).
| Sensitivity analysis
Influence analyses using the leave-one-out approach were performed for the meta-analyses to evaluate the stability of the RR and heterogeneity (Tables 2 and 3 ). These analyses showed that the corresponding RRs were not significantly altered, demonstrating confidence that the overall meta-analyses were robust, despite the moderate to high heterogeneity detected.
| Publication bias
The funnel plots analysis presented in Figure 4A ,B indicated a low likelihood of publication bias. An itemized assessment of specific variables of the DNA ploidy methodology itself was performed to further validate the funnel plots. Such variables included case selection, nuclei isolation and monolayer staining method, image-capture hardware and software (whether automated or manual), image editing (to eliminate overlapping and damaged nuclei as well as debris), endogenous control and ploidy classification criteria, including CV values. From a qualitative viewpoint, the studies were found to be considerably similar in their description of such variables. All five studies reviewed herein adhered strictly to previously published criteria. 25 Tissue preparation was based on two to six 50-lm tissue sections from FFPE biopsies, enzymatically digested to yield a suspension of cell nuclei, from which monolayers were produced and stained using the Feulgen method. All authors reported using an automated image-capture system, which also allowed manual fine-tune editing post hoc. Lymphocytes were used as an internal control to ascertain the location of the diploid peak in all studies, and the ploidy classification criteria were also the same for all articles and were based on the guidelines by the European Society for Analytical Cellular Pathology. 25 All authors reported a CV≤5 for the diploid peak.
| DISCUSSION
DNA content analysis has been proposed as a good prognostic marker of OPMD, in which an aneuploid diagnosis was associated with The first meta-analysis demonstrated that aneuploidy increased the risk of malignant transformation (RR=3.12). The leave-one-out sensitivity analysis proved this finding robust, which reinforces the ability of DNA aneuploidy to identify high-risk lesions, as established by image cytometry, as previously proposed. 16, [21] [22] [23] [24] Whilst an aneuploid result may mean a high risk of malignant change, a diploid outcome does not necessarily mean no risk at all.
The second meta-analysis revealed that a diploid result carries approximately 80% risk of not undergoing malignant transformation (Figure 3 ), although 20% of cases may still be at risk of transforming.
The most likely explanations for such a limitation are sampling error of the affected mucosa at biopsy, which risks false-negative results;
and limitation of the DNA ploidy method itself, which may not be sensitive enough to detect minor degrees of chromosomal instability on a single sample. 26 This may occur due to the nuclei being isolated from thick sections of paraffin blocks without prior microdissection of the specimen, which may "dilute out" the aneuploid cells and compromise the sensitivity of the test.
The advantage of ploidy analysis over the traditional method of qualitative dysplasia grading is objectivity. Identifying and scoring epithelial dysplasia demands an experienced and trained pathologist, which is costly and of limited availability in many health systems, especially in developing areas of the world. Such an approach also suffers from subjectivity, as many studies have shown considerable variation in agreement levels both inter-and intra-examiner. [27] [28] [29] [30] [31] Ploidy analysis is regarded as an objective method, based on automated image analysis and well-established strict threshold criteria for ploidy classification. 25 This provides evidence that this study brings added value to the current knowledge on objective approaches to manage OPMD.
The reviewed studies were all conducted in developed countries, which may present a lower incidence of some risk factors for the development of oral cancer, such as nutritional deficiencies and low 
